搜索临床试验以:Third-party Donors
总计862个结果
-
University of Edinburgh完全的
-
Christopher Dvorak不再可用急性髓性白血病 | 白细胞疾病 | 急性淋巴细胞白血病 | 慢性粒细胞白血病 | 骨髓增生异常综合症 | 血细胞减少症 | 免疫缺陷 | 淋巴瘤 | 骨髓衰竭 | 骨质疏松症 | 血红蛋白病 | 内在红细胞异常引起的贫血美国
-
University of VirginiaNational Heart, Lung, and Blood Institute (NHLBI); Astellas Pharma Global Development, Inc.完全的
-
Vanderbilt University Medical CenterUniversity of California, Los Angeles; University of California, San Francisco; Stanford University 和其他合作者终止
-
Cedars-Sinai Medical CenterAlexion Pharmaceuticals完全的心脏同种异体移植血管病变 | 抗体介导的排斥反应 | 左心室功能不全 | 心脏移植的超急性排斥反应 | 心脏移植物功能障碍美国
-
Cerus Corporation终止
-
Medical College of WisconsinNational Heart, Lung, and Blood Institute (NHLBI); University of California, Los Angeles; Columbia... 和其他合作者完全的
-
Memorial Sloan Kettering Cancer Center终止
-
University of Chicago终止急性髓系白血病 (AML) | 骨髓增生异常综合征 (MDS)美国
-
Ural State Medical UniversityUral Institute of Cardiology; De Haar Research Task Force; Ural Federal University; Transfiguration...完全的
-
Assistance Publique - Hôpitaux de ParisCSL Behring; Association ASLUMARE完全的
-
Medical University of WarsawMinistry of Science and Higher Education, Poland主动,不招人
-
Federal Research Institute of Pediatric Hematology...完全的
-
Oslo University HospitalUniversity of Oslo; South-Eastern Norway Regional Health Authority完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Celgene Corporation完全的
-
Medical University of GrazJohannes Kepler University of Linz; Fresenius Kabi Austria GmbH, Graz完全的
-
Heidelberg University未知
-
Assistance Publique - Hôpitaux de ParisAgence de La Biomédecine完全的
-
The Methodist Hospital Research InstituteVeloxis Pharmaceuticals撤销肾移植急性排斥反应 | 肾脏疾病,终末期 | 供体特异性抗体
-
University of Colorado, DenverChildren's Hospital Colorado终止
-
Center for International Blood and Marrow Transplant...National Marrow Donor Program完全的